NEOADJUVANT HIGH-DOSE METHOTREXATE, CISPLATIN, AND DOXORUBICIN FOR THE MANAGEMENT OF PATIENTS WITH NONMETASTIC OSTEOSARCOMA

被引：0
|
作者：
WEINER, MA
HARRIS, MB
LEWIS, M
JONES, R
SHERRY, H
FEURER, EJ
JOHNSON, J
LAHMAN, E
机构：
[1] MT SINAI MED CTR,DEPT NEOPLAST DIS,NEW YORK,NY 10029
[2] MT SINAI MED CTR,DEPT ORTHOPED,NEW YORK,NY 10029
[3] MT SINAI MED CTR,DEPT BIOMATH SCI,NEW YORK,NY 10029
[4] HOSP JOINT DIS,INST ORTHOPED,BONE TUMOR SERV,NEW YORK,NY 10003
来源：
CANCER TREATMENT REPORTS | 1986年 / 70卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1431 / 1432
页数：2
相关论文
共 50 条
  • [31] Neoadjuvant multidrug chemotherapy including High-Dose Methotrexate modifies VEGF expression in Osteosarcoma: an immunohistochemical analysis
    Rossi, Barbara
    Schinzari, Giovanni
    Maccauro, Giulio
    Scaramuzzo, Laura
    Signorelli, Diego
    Rosa, Michele A.
    Fabbriciani, Carlo
    Carlo, Barone
    BMC MUSCULOSKELETAL DISORDERS, 2010, 11
  • [32] Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases:: treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide
    Bacci, G
    Briccoli, A
    Ferrari, S
    Sæter, G
    Donati, D
    Longhi, A
    Manfrini, M
    Bertoni, F
    Rimondini, S
    Monti, C
    Forni, C
    ONCOLOGY REPORTS, 2000, 7 (02) : 339 - 346
  • [33] The efficacy and safety comparison of first-line chemotherapeutic agents (high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide) for osteosarcoma: a network meta-analysis
    Bin Zhang
    Yan Zhang
    Rongzhen Li
    Jiazhen Li
    Xinchang Lu
    Yi Zhang
    Journal of Orthopaedic Surgery and Research, 15
  • [34] The efficacy and safety comparison of first-line chemotherapeutic agents (high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide) for osteosarcoma: a network meta-analysis
    Zhang, Bin
    Zhang, Yan
    Li, Rongzhen
    Li, Jiazhen
    Lu, Xinchang
    Zhang, Yi
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2020, 15 (01)
  • [35] Management of Patients with Acute Methotrexate Nephrotoxicity with High-Dose Leucovorin
    Flombaum, Carlos D.
    Liu, Dazhi
    Yan, Shirley Qiong
    Chan, Amelia
    Mathew, Sherry
    Meyers, Paul A.
    Glezerman, Ilya G.
    Muthukumar, Thangamani
    PHARMACOTHERAPY, 2018, 38 (07): : 714 - 724
  • [36] Prospective evaluation of renal function in pediatric and adult patients treated with high-dose ifosfamide, cisplatin and high-dose methotrexate
    Ferrari, S
    Pieretti, F
    Verri, E
    Tolentinis, L
    Cesari, M
    Versari, M
    Zolezzi, C
    Lamanna, G
    Bacci, G
    ANTI-CANCER DRUGS, 2005, 16 (07) : 733 - 738
  • [37] High-dose Methotrexate Is Effective in Osteosarcoma so What Is the Problem?
    Cohen, Ian Joseph
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2009, 31 (12) : 892 - 894
  • [38] ETOPOSIDE, CYCLOPHOSPHAMIDE, CISPLATIN, AND DOXORUBICIN AS NEOADJUVANT CHEMOTHERAPY FOR OSTEOSARCOMA
    CASSANO, WF
    GRAHAMPOLE, J
    DICKSON, N
    CANCER, 1991, 68 (09) : 1899 - 1902
  • [39] Outpatient administration of high-dose methotrexate for osteosarcoma treatment in Brazil
    Macedo, C. R.
    Cappellano, A. M.
    Noguchi, D. T.
    Martinho, A. P.
    Dias, C. G.
    Dias, C. G.
    Malheiros, R. C.
    Dutra, A. H.
    Grings, M.
    Pires, A. L.
    Petrilli, A. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [40] THE UNCLEAR ROLE OF HIGH-DOSE METHOTREXATE IN ADULT OSTEOSARCOMA (OS)
    RICHARDS, JM
    VOGELZANG, NJ
    SIMON, M
    CLINICAL RESEARCH, 1986, 34 (04): : A932 - A932
12345